Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal Cytochrome P450 3A4/CYP3A4 antibody. Carrier free. Suitable for IP, WB, IHC-P and reacts with Human, Transfected cell line - Human samples. Cited in 2 publications.
View Alternative Names
CYP3A3, CYP3A4, Cytochrome P450 3A4, Albendazole monooxygenase (sulfoxide-forming), Albendazole sulfoxidase, CYPIIIA3, CYPIIIA4, Cholesterol 25-hydroxylase, Cytochrome P450 3A3, Cytochrome P450 HLp, Cytochrome P450 NF-25, Cytochrome P450-PCN1, Nifedipine oxidase, Quinine 3-monooxygenase
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human liver tissue sections labeling Cytochrome P450 3A4/CYP3A4 with purified ab124921 at 1/400 dilution (0.35 μg/ml). Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab124921).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)
ab124921 (unpurified), at a 1/100 dilution, staining Cytochrome P450 3A4/CYP3A4 in paraffin embedded Human liver tissue by Immunohistochemistry.
This data was developed using the same antibody clone in a different buffer formulation containing Tris glycine, glycerol and sodium azide (ab124921).
- IP
Unknown
Immunoprecipitation - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)
ab124921 (purified) at 1/20 dilution (1ug) immunoprecipitating Cytochrome P450 3A4/CYP3A4 in Human liver lysates.
Lane 1 : Human liver lysates 10ug
Lane 2 (+) : ab124921 & Human liver lysates
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab124921 in Human liver lysates
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was at 1/1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab124921).
All lanes:
Immunoprecipitation - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (<a href='/en-us/products/primary-antibodies/cytochrome-p450-3a4-cyp3a4-antibody-epr6202-ab124921'>ab124921</a>)
Predicted band size: 57 kDa
false
- WB
Unknown
Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)
HepG2 cells were incubated at 37°C for 48h with vehicle control (0 μM) and different concentrations of nicardipine hydrochloride (ab120531) in DMSO. Increased expression of Cytochrome P450 3A4/CYP3A4 (ab124921) correlates with an increase in nicardipine hydrochloride concentration, as described in literature. Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 10μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with ab124921 at 1/10000 dilution and ab9484 at 1 μg /ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution. This data was developed using the same antibody clone in a different buffer formulation containing Tris glycine, glycerol and sodium azide (ab124921).
All lanes:
Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (<a href='/en-us/products/primary-antibodies/cytochrome-p450-3a4-cyp3a4-antibody-epr6202-ab124921'>ab124921</a>)
Predicted band size: 57 kDa
true
Exposure time: 20min
- WB
Supplier Data
Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab124921).
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
ab205606 was used as a tag loading control.
The detection of CYP3A4 recombinant protein or over -expressed protein with a C - terminal tag yielded a negative result because the immunogen of this product is located at the C - terminal of CYP3A4.
All lanes:
Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (<a href='/en-us/products/primary-antibodies/cytochrome-p450-3a4-cyp3a4-antibody-epr6202-ab124921'>ab124921</a>) at 1/1000 dilution
Lane 1:
293T cells transfected with an empty vector containing a Flag tag whole cell lysate at 20 µg
Lane 2:
293T cells transfected with a human CYP3A4 expression vector containing a N-terminal Flag tag whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 50 kDa
false
Exposure time: 1s
- OI-RD Scanning
Supplier Data
OI-RD Scanning - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen) of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol and sodium azide (ab124921).
Related conjugates and formulations (4)
-
Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202]
-
Biotin Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202]
Reactivity data
Product details
ab245774 is the carrier-free version of ab124921.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CYP3A4 is involved in the metabolism of approximately half of all drugs used in clinical settings making it one of the most significant enzymes in drug metabolism. It does not usually function as part of a larger complex but acts individually on various substrates. Besides xenobiotic metabolism CYP3A4 also metabolizes steroids and other endogenous molecules. Climbazole an antifungal agent is a substrate for CYP3A4 demonstrating the enzyme's broad substrate specificity within the body's complex biochemical environment.
Pathways
CYP3A4 plays a central role in the drug metabolism pathway and the synthesis and metabolism of steroids. These pathways involve other cytochrome P450 enzymes including CYP2D6 and CYP2C9 which often work alongside CYP3A4 to metabolize compounds. The pathway's coordinated activities ensure proper drug metabolism and hormone regulation. Understanding the involvement of CYP3A4 in these pathways is critical for drug development and determining drug-drug interactions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Organogenesis 18:2061263 PubMed35435152
2022
Applications
Unspecified application
Species
Unspecified reactive species
Translational andrology and urology 10:4275-4287 PubMed34984192
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com